Lv5
970 积分 2024-09-18 加入
Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs
13小时前
已完结
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance
12天前
已完结
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
13天前
已完结
BCL-2 inhibition in haematological malignancies: Clinical application and complications
13天前
已完结
The path to venetoclax resistance is paved with mutations, metabolism, and more
14天前
已完结
Glaucoma: now and beyond
19天前
已完结
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
1个月前
已完结
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance
1个月前
已完结
Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies
1个月前
已关闭
Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials
1个月前
已完结
皖公网安备34019202002308
